 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 3074 | 回復(fù): 10 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
[求助]
accept with major revision 但意見不多
|
|||
|
Dear Dr Peng, I regret to inform you that your work can be reconsidered for publication only with extensive revisions to your manuscript. The reviewers' advice on the necessary revisions and their comments are appended below. If you are willing to undertake the required amendments, please submit a point by point response listing your changes or justifications to the reviewers' comments when you submit the revised manuscript. With warm regards, Toshio Kitamura Reviewers' comments: A Editorial Board This study, which is carefully performed, is an interesting one. Both reviewers recognized some merit in this paper. Please carefully respond all concerns raised by the reviewers. I have one minor concern Regarding statistic p values, the authors should described them as more accurate number (for example <0.001) instead of 0.00. Reviewer #1: This paper describes the long-term effects of laparoscopic splenectomy (LS) for patients with chronic immune thrombocytopenia (ITP). They also tried to determine the predictive factors for promising hematological outcomes. Along with the advancement in some new drugs including rituximab and thrombopoietin receptor agonists, it is important to re-examine and analyze the long-term effects of LS and the predictive factors for good outcomes. Major issues 1. They retrospectively analyzed the data in 92 patients who underwent LS for chronic ITP. Their remission rate (76.1%) is relatively favorable and indicated that LS is still one of the treatment options for chronic ITP even in an era of new drugs. 2. Using multivariate logistic regression analysis, they showed that only the platelet counts on postoperative months 3 (POM3) was a significant independent prognostic factor for long-time response to LS. This information is also useful to estimate the long-time response for each patient. 3. The authors previously reported about LS for ITP patients (ref 11, Int J Hematol 94:533-538) . In this paper, they analysed 10 ITP patients who underwent LS because of severe thrombocytopenia, from April 2006 to Jan 2011. They have to make clear whether these 10 patients were overlapped with 92 (from Nov 2006 to Aug 2012) patients in the current report or not. 4. They mentioned that one patient has died of severe pulmonary infection after LS on POD 5. I want to know whether this patient was suffered by overwhelming postsplenectomy infection (OPSI). It is also interesting to know whether these patients were given pneumococcal vaccine around LS in their institute. Minor issues 1. In Table 2, they use abbreviated words "RG" and "NG". They should indicate what these abbreviations stand for. Reviewer #2: The authors described the clinical research entitled predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. In this paper, they clearly demonstrated that platelet count on POM3 was significant independent predictor of long-term favorable outcome. Their conclusions are almost acceptable, however, several questions are raised up as below. 1) Several investigators already reported that young patients showed higher CR responses of splenectomy than those in elderly patients. However, CR rate in this paper was thought to be lower (53.3 %) than expected. 2) It was reported that the good response to IVIG might be available for predictor of successful splenectomy. Did you check this phenomenon in your study? 3) The importance of platelet raise after splenectomy was already well known in hematologists. Some papers reported POM 1 was available as predictable indicator.However, you mentioned the POM3 was significant, not POM 1. You should explain the reason on 求助。有戲沒？？？徹夜難眠55555555555 |
回復(fù)此樓» 猜你喜歡
284求調(diào)劑
已經(jīng)有13人回復(fù)
-
材料科學(xué)與工程調(diào)劑
已經(jīng)有5人回復(fù)
-
346求調(diào)劑 一志愿070303有機(jī)化學(xué)
已經(jīng)有4人回復(fù)
-
329求調(diào)劑
已經(jīng)有8人回復(fù)
-
一志愿南航 335分 | 0856材料化工 | GPA 4.07 | 有科研經(jīng)歷
已經(jīng)有7人回復(fù)
-
322求調(diào)劑
已經(jīng)有8人回復(fù)
-
考研調(diào)劑
已經(jīng)有5人回復(fù)
-
307求調(diào)劑
已經(jīng)有11人回復(fù)
-
292求調(diào)劑
已經(jīng)有9人回復(fù)
-
本科211生物醫(yī)學(xué)工程085409求調(diào)劑339分
已經(jīng)有3人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對您同樣有幫助:
- 投稿從沒人審稿——Reject——Major——Minor——Major——Accept
已經(jīng)有14人回復(fù)
- JAPS投稿疑問，只有一個(gè)審稿人意見，但是是major revision
已經(jīng)有11人回復(fù)
- 投稿狀態(tài)是拒稿，但編輯部給了個(gè) Major Revision，這是什么情況，請大家給個(gè)意見啊
已經(jīng)有10人回復(fù)
- 這種minor revision是不是相當(dāng)于接收了，有必要再潤色嗎？
已經(jīng)有10人回復(fù)
- 審稿人給出的意見是extensive English revision，這是讓我大范圍修改語言嗎？
已經(jīng)有17人回復(fù)
- 一篇重投的文章收到一個(gè)“accept”和兩個(gè)“major revision”，結(jié)果被拒
已經(jīng)有14人回復(fù)
- SCI投稿過程總結(jié)
已經(jīng)有124人回復(fù)
- 初次投稿IEEE 需要major revision 大家給點(diǎn)意見？
已經(jīng)有7人回復(fù)
- major revision后直接接收的可能性有多大？
已經(jīng)有8人回復(fù)
- Process Biochemistry 后 accept after major revision
已經(jīng)有13人回復(fù)
- major revision 大家看有希望嗎
已經(jīng)有9人回復(fù)
- major revision完事后，幾天能收到意見~
已經(jīng)有23人回復(fù)
- 求助，accept with minor revision，該怎么修改？
已經(jīng)有7人回復(fù)
- Major Revision機(jī)會還大不？
已經(jīng)有31人回復(fù)
- 一篇文章major revision后，審稿意見已經(jīng)回來1周了，還是沒有消息
已經(jīng)有23人回復(fù)
- major revision 后該怎么辦？
已經(jīng)有16人回復(fù)
janesonimr
至尊木蟲 (知名作家)
- 應(yīng)助: 14 (小學(xué)生)
- 貴賓: 0.001
- 金幣: 51579.9
- 散金: 154
- 紅花: 62
- 沙發(fā): 1
- 帖子: 6971
- 在線: 1127.3小時(shí)
- 蟲號: 1245030
- 注冊: 2011-03-25
- 性別: GG
- 專業(yè): 金屬非晶態(tài)、準(zhǔn)晶和納米晶
4樓2013-03-14 10:54:15
fsmyn
木蟲 (正式寫手)
- 應(yīng)助: 61 (初中生)
- 金幣: 4766.6
- 散金: 11
- 紅花: 1
- 帖子: 709
- 在線: 1319.9小時(shí)
- 蟲號: 1538563
- 注冊: 2011-12-15
- 專業(yè): 信號理論與信號處理
2樓2013-03-14 10:51:37
3樓2013-03-14 10:53:49
nono2009
超級版主 (文學(xué)泰斗)
No gains, no pains.
-
專家經(jīng)驗(yàn): +21105 - SEPI: 10
- 應(yīng)助: 28684 (院士)
- 貴賓: 513.911
- 金幣: 2555230
- 散金: 27828
- 紅花: 2148
- 沙發(fā): 66666
- 帖子: 1602255
- 在線: 65200.9小時(shí)
- 蟲號: 827383
- 注冊: 2009-08-13
- 性別: GG
- 專業(yè): 工程熱物理與能源利用
- 管轄: 科研家籌備委員會
5樓2013-03-14 11:52:11
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料工程專碩求調(diào)劑 +6 | hyl3153942 2026-03-29 | 6/300 |
|
|---|---|---|---|---|
|
|
[考研] 環(huán)境科學(xué)與工程334分求調(diào)劑 +6 | 王一一依依 2026-03-30 | 8/400 |
|
|
[考研] 310求調(diào)劑 +9 | 爭取九點(diǎn)睡 2026-03-30 | 9/450 |
|
|
|
[考研] 南京大學(xué)化學(xué)調(diào)劑 +10 | 景隨風(fēng) 2026-03-29 | 15/750 |
|
|
|
[考研] 一志愿南開大學(xué)0710生物學(xué)359求調(diào)劑 +5 | 兔兔兔111223314 2026-03-29 | 5/250 |
|
|
|
[考研] 334分 一志愿武理 材料求調(diào)劑 +12 | 李李不服輸 2026-03-26 | 12/600 |
|
|
|
[考研] 求調(diào)劑 +6 | 家佳佳佳佳佳 2026-03-29 | 6/300 |
|
|
|
[考研] 一志愿華東師范大學(xué)有機(jī)化學(xué)專業(yè)，初試351分，復(fù)試被刷求調(diào)劑! +5 | 真名有冰 2026-03-29 | 6/300 |
|
|
|
[考研] 【求調(diào)劑】085601材料工程專碩 | 總分272 | +7 | 腳滑的守法公民 2026-03-27 | 7/350 |
|
|
|
[考研] 327求調(diào)劑 +6 | 汲亦昊 2026-03-29 | 6/300 |
|
|
|
[考研] 材料學(xué)碩333求調(diào)劑 +11 | 北道巷 2026-03-24 | 11/550 |
|
|
|
[碩博家園] 招收生物學(xué)/細(xì)胞生物學(xué)調(diào)劑 +4 | IceGuo 2026-03-26 | 5/250 |
|
|
|
[考研] 322求調(diào)劑 +5 | 舊吢 2026-03-24 | 5/250 |
|
|
|
[考研] 286求調(diào)劑 +12 | PolarBear11 2026-03-26 | 12/600 |
|
|
|
[考研] 291求調(diào)劑 +15 | hhhhxn.. 2026-03-23 | 21/1050 |
|
|
|
[考研] 266求調(diào)劑 +11 | 陽陽哇塞 2026-03-27 | 12/600 |
|
|
|
[考研] 296求調(diào)劑 +4 | 汪��？！ 2026-03-25 | 7/350 |
|
|
|
[考研] 【2026考研調(diào)劑】制藥工程 284分 求相關(guān)專業(yè)調(diào)劑名額 +4 | 袁奐奐 2026-03-25 | 8/400 |
|
|
|
[考研] 340求調(diào)劑 +5 | 話梅糖111 2026-03-24 | 5/250 |
|
|
|
[考研]
 085404電子信息284分求調(diào)劑
+4
|
13659058978 2026-03-24 | 4/200 |
|